Streetbeat News

Revenues

AMC

CRWD

NVDA

TSLA

VZ

Major U.S. indices closed higher on Monday, with notable movements in Nvidia, CrowdStrike, AMC, Verizon, and Tesla stocks. Nvidia rose due to new AI chip development, CrowdStrike fell after an IT outage, AMC increased following debt restructuring plans, Verizon dropped after missing sales estimates, and Tesla rose ahead of its earnings report.

Portfolio Pulse from Benzinga Neuro

July 23, 2024 | 3:10 am

AME

AMETEK (NYSE:AME) has outperformed the market over the past 10 years with an average annual return of 13.05%, resulting in a $1000 investment growing to $3,362.56. The company currently has a market capitalization of $40.04 billion.

Portfolio Pulse from Benzinga Insights

July 22, 2024 | 9:30 pm

UTHR

United Therapeutics (NASDAQ:UTHR) has significantly outperformed the market over the past 5 years, delivering an average annual return of 33.79%. A $1000 investment in UTHR 5 years ago would be worth $4,326.61 today. The article highlights the power of compounded returns.

Portfolio Pulse from Benzinga Insights

July 22, 2024 | 9:30 pm

BRO

Brown & Brown (NYSE:BRO) reported Q2 2024 adjusted EPS of $0.93, beating the $0.88 estimate. Sales were $1.178 billion, surpassing the $1.144 billion estimate and showing a 12.51% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 22, 2024 | 9:29 pm

SAP

SAP SE (NYSE:SAP) reported its Q2 financial results, missing analyst estimates for both earnings and sales. Despite this, the company saw significant growth in its cloud revenue and backlog, and shares rose 4.80% after-hours. SAP reiterated its fiscal year 2024 outlook and provided strong guidance for 2025.

Portfolio Pulse from Erica Kollmann

July 22, 2024 | 9:26 pm

SMBK

SmartFinancial (NYSE:SMBK) reported Q2 2024 adjusted EPS of $0.46, beating the $0.39 estimate. Sales were $40.418M, surpassing the $40.072M estimate. Despite the earnings beat, EPS decreased by 11.54% YoY, while sales increased by 4.43% YoY.

Portfolio Pulse from Benzinga Newsdesk

July 22, 2024 | 9:08 pm

MEDP

Medpace Holdings Inc (NASDAQ:MEDP) shares fell in after-hours trading following mixed Q2 financial results and a revision of forward guidance. The company reported Q2 revenue of $528.1 million, slightly below estimates, and EPS of $2.75, above estimates. Medpace revised its full-year 2024 revenue forecast downward but raised its earnings outlook. Shares were down 13.08% at $380.

Portfolio Pulse from Adam Eckert

July 22, 2024 | 9:08 pm

CATY

Cathay General (NASDAQ: CATY) reported Q2 2024 adjusted EPS of $0.96, beating the estimate of $0.94. However, sales were $178.531M, missing the $179.184M estimate and showing a 12.76% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 22, 2024 | 9:02 pm

CALX

In the last three months, 6 analysts have published ratings on Calix (NYSE:CALX), with a mix of bullish and indifferent perspectives. Analysts have set 12-month price targets for Calix, with an average target of $40.83, a high of $45.00, and a low of $30.00. Recent actions include JP Morgan raising its target to $41.00 and Jefferies lowering it to $30.00. Calix faces revenue challenges but shows strong net margin and asset management.

Portfolio Pulse from Benzinga Insights

July 22, 2024 | 9:00 pm

HCA

HCA Healthcare (NYSE:HCA) has significantly outperformed the market over the past decade, delivering an average annual return of 17.46%. A $1000 investment in HCA 10 years ago would now be worth $5,112.02. The article highlights the power of compounded returns over time.

Portfolio Pulse from Benzinga Insights

July 22, 2024 | 9:00 pm